Market data including bonds, unit trusts and fuel prices
It’s a mystery why men who shave (and possibly women who shave) would find an ad about men being their best selves ‘inappropriate’
Political debates around the Reserve Bank are fast being exposed as factional fights within the ANC rather than anything to do with the economy
Business and labour are questioning the governing party's jobs plans unveiled in its election manifesto
Former CBS Corporation CEO Les Moonves was ousted after accusations of sexual misconduct from a dozen women
As economic growth slows and global trade tensions continue, the region is expected to do comparatively well
Senzeni Zokwana said his department is finalising the allocation of 15-year fishing rights to hundreds of co-operatives around the country
Britain summons Zimbabwe’s ambassador to London to express its deep concern
'Hurry Hurry' Johanneson scored 67 goals and played a role in helping Leeds United to win promotion to the First Division in 1964
From Pantone’s Colour of the Year to maximalism, we’ve lined up our favourite interior trends to tap into
The settlement ends a long-standing dispute over medical devices
SA’s biggest private hospital group presented its final argument to the Competition Tribunal
Business Life Healthcare CEO Shrey Viranna joins Business Day TV to discuss the company’s deal with Radiant Life
News of the sale lifted the health company’s share price which plummeted in 2018 amid concerns about its indebtedness
Cerba, a Paris-based medical company, will hold a 51% stake in a joint venture with Lancet
Private equity firm Coast2Coast has been offloading the company's shares to meet margin calls
SPONSORED | Medshield’s proposed alternative reimbursement model focuses on being more cost effective
Coast2Coast has been offloading Ascendis shares in recent weeks to meet obligations to lenders
The new joint venture with Pfizer is expected to generate total annual cost savings of £500m by 2022
Changes to its debt covenant if it fails to conclude the €740m sale of its nutritionals business to Lactalis by the end of the year alarmed investors
US-headquartered pharmaceutical group Mylan will have option to buy portfolio
SA’s biggest medical scheme wants an assertion about possible anti-competitive behaviour to be withdrawn
The involvement of a Discovery Health executive in the Competition Commission's probe into the healthcare market has stirred a hornet’s nest
The company's shares have fallen 78% so far in 2018
The conglomerate faces a threat to revenues in 2024 when the patent on blockbuster heart drug Xarelto runs out
Former top sales executive at Insys Therapeutics Alex Burlakoff is one of the first charged in the mounting legal backlash to the US opioid epidemic
Britain’s largest drugmaker is paying $75 a share for the business, a 110% premium to the 30-day average price
SPONSORED | SA’s health system value measure is below the 16-country average
Life Healthcare delivers strong financial results, reporting solid revenue and earnings growth
Life healthcare has delivered solid annual numbers and the group’s CEO Shrey Viranna joined Business Day TV for more perspective on the year that was.
Published by Tiso Blackstar and distributed with the Financial Mail on the last Thursday of every month except December and January.
